After melanoma surgery, Bristols Opdivo offers new care standard Ruby Khatun Khatun12 Sep 2017 3:45 AM GMTMADRID: Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients...